7-41960988-A-AT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000168.6(GLI3):​c.*3341dupA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 151,934 control chromosomes in the GnomAD database, including 1,527 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1523 hom., cov: 30)
Exomes 𝑓: 0.16 ( 4 hom. )

Consequence

GLI3
NM_000168.6 3_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.849

Publications

1 publications found
Variant links:
Genes affected
GLI3 (HGNC:4319): (GLI family zinc finger 3) This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI3 Gene-Disease associations (from GenCC):
  • Greig cephalopolysyndactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • Pallister-Hall syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics, Orphanet
  • polydactyly, postaxial, type A1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • polysyndactyly 4
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • tibial hemimelia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • acrocallosal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postaxial polydactyly type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-41960988-A-AT is Benign according to our data. Variant chr7-41960988-A-AT is described in ClinVar as [Benign]. Clinvar id is 360156.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.179 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI3NM_000168.6 linkc.*3341dupA 3_prime_UTR_variant Exon 15 of 15 ENST00000395925.8 NP_000159.3 P10071

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI3ENST00000395925.8 linkc.*3341dupA 3_prime_UTR_variant Exon 15 of 15 5 NM_000168.6 ENSP00000379258.3 P10071
GLI3ENST00000677605.1 linkc.*3341dupA 3_prime_UTR_variant Exon 15 of 15 ENSP00000503743.1 P10071
GLI3ENST00000678429.1 linkc.*3341dupA 3_prime_UTR_variant Exon 15 of 15 ENSP00000502957.1 P10071
GLI3ENST00000677288.1 linkc.*3341dupA 3_prime_UTR_variant Exon 14 of 14 ENSP00000503986.1 A0A7I2V4X9

Frequencies

GnomAD3 genomes
AF:
0.123
AC:
18577
AN:
151382
Hom.:
1521
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0329
Gnomad AMI
AF:
0.266
Gnomad AMR
AF:
0.0734
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.0675
Gnomad SAS
AF:
0.189
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.176
Gnomad OTH
AF:
0.103
GnomAD4 exome
AF:
0.162
AC:
70
AN:
432
Hom.:
4
Cov.:
0
AF XY:
0.173
AC XY:
45
AN XY:
260
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.164
AC:
70
AN:
426
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.123
AC:
18572
AN:
151502
Hom.:
1523
Cov.:
30
AF XY:
0.122
AC XY:
9062
AN XY:
74004
show subpopulations
African (AFR)
AF:
0.0328
AC:
1356
AN:
41322
American (AMR)
AF:
0.0734
AC:
1115
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3468
East Asian (EAS)
AF:
0.0673
AC:
345
AN:
5128
South Asian (SAS)
AF:
0.189
AC:
906
AN:
4786
European-Finnish (FIN)
AF:
0.191
AC:
2000
AN:
10446
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.176
AC:
11967
AN:
67854
Other (OTH)
AF:
0.102
AC:
214
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
780
1561
2341
3122
3902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0419
Hom.:
54
Bravo
AF:
0.106

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Greig cephalopolysyndactyly syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polydactyly Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pallister-Hall syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138425063; hg19: chr7-42000586; COSMIC: COSV67886193; COSMIC: COSV67886193; API